163 related articles for article (PubMed ID: 11507218)
1. Intratumoral spread and increased efficacy of a p53-VP22 fusion protein expressed by a recombinant adenovirus.
Wills KN; Atencio IA; Avanzini JB; Neuteboom S; Phelan A; Philopena J; Sutjipto S; Vaillancourt MT; Wen SF; Ralston RO; Johnson DE
J Virol; 2001 Sep; 75(18):8733-41. PubMed ID: 11507218
[TBL] [Abstract][Full Text] [Related]
2. Efficient translocation and apoptosis induction by adenovirus encoded VP22-p53 fusion protein in human tumor cells in vitro.
Roy I; Holle L; Song W; Holle E; Wagner T; Yu X
Anticancer Res; 2002; 22(6A):3185-9. PubMed ID: 12530063
[TBL] [Abstract][Full Text] [Related]
3. Poor intercellular transport and absence of enhanced antiproliferative activity after non-viral gene transfer of VP22-P53 or P53-VP22 fusions into p53 null cell lines in vitro or in vivo.
Zavaglia D; Lin EH; Guidetti M; Pluquet O; Hainaut P; Favrot MC; Coll JL
J Gene Med; 2005 Jul; 7(7):936-44. PubMed ID: 15754307
[TBL] [Abstract][Full Text] [Related]
4. VP22-mediated intercellular transport of p53 in hepatoma cells in vitro and in vivo.
Zender L; Kühnel F; Köck R; Manns M; Kubicka S
Cancer Gene Ther; 2002 Jun; 9(6):489-96. PubMed ID: 12032659
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy by intrahepatic and intratumoral trafficking of p53-VP22 induces regression of liver tumors.
Zender L; Köck R; Eckhard M; Frericks B; Gösling T; Gebhardt T; Drobek S; Galanski M; Kühnel F; Manns M; Kubicka S
Gastroenterology; 2002 Aug; 123(2):608-18. PubMed ID: 12145813
[TBL] [Abstract][Full Text] [Related]
6. Intercellular trafficking of VP22, a herpes simplex virus type 1 tegument protein.
Bamdad T; Bell JC
Iran Biomed J; 2007 Jan; 11(1):53-7. PubMed ID: 18051705
[TBL] [Abstract][Full Text] [Related]
7. Induction of insolubility by herpes simplex virus VP22 precludes intercellular trafficking of N-terminal Apoptin-VP22 fusion proteins.
Rutjes SA; Bosma PJ; Rohn JL; Noteborn MH; Wesseling JG
J Mol Med (Berl); 2003 Sep; 81(9):558-65. PubMed ID: 12879152
[TBL] [Abstract][Full Text] [Related]
8. VP22 does not significantly enhance enzyme prodrug cancer gene therapy as a part of a VP22-HSVTk-GFP triple fusion construct.
Hakkarainen T; Wahlfors T; Meriläinen O; Loimas S; Hemminki A; Wahlfors J
J Gene Med; 2005 Jul; 7(7):898-907. PubMed ID: 15759279
[TBL] [Abstract][Full Text] [Related]
9. Intercellular delivery of functional p53 by the herpesvirus protein VP22.
Phelan A; Elliott G; O'Hare P
Nat Biotechnol; 1998 May; 16(5):440-3. PubMed ID: 9592391
[TBL] [Abstract][Full Text] [Related]
10. VP22-mediated intercellular transport correlates with enhanced biological activity of MybEngrailed but not (HSV-I) thymidine kinase fusion proteins in primary vascular cells following non-viral transfection.
Sheridan PJ; Lawrie A; Crossman DC; Holt CM; Newman CM
J Gene Med; 2005 Mar; 7(3):375-85. PubMed ID: 15543525
[TBL] [Abstract][Full Text] [Related]
11. Fusion of herpes simplex virus thymidine kinase to VP22 does not result in intercellular trafficking of the protein.
Beerens AM; Rots MG; de Vries EF; Haisma HJ
Int J Mol Med; 2007 May; 19(5):841-9. PubMed ID: 17390091
[TBL] [Abstract][Full Text] [Related]
12. VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell death.
Liu CS; Kong B; Xia HH; Ellem KA; Wei MQ
J Gene Med; 2001; 3(2):145-52. PubMed ID: 11318113
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus VP22-human papillomavirus E2 fusion proteins produced in mammalian or bacterial cells enter mammalian cells and induce apoptotic cell death.
Roeder GE; Parish JL; Stern PL; Gaston K
Biotechnol Appl Biochem; 2004 Oct; 40(Pt 2):157-65. PubMed ID: 14709162
[TBL] [Abstract][Full Text] [Related]
14. Intercellular trafficking of VP22-GFP fusion proteins is not observed in cultured mammalian cells.
Fang B; Xu B; Koch P; Roth JA
Gene Ther; 1998 Oct; 5(10):1420-4. PubMed ID: 9930348
[TBL] [Abstract][Full Text] [Related]
15. Intercellular trafficking and enhanced in vivo antitumour activity of a non-virally delivered P27-VP22 fusion protein.
Zavaglia D; Favrot MC; Eymin B; Tenaud C; Coll JL
Gene Ther; 2003 Feb; 10(4):314-25. PubMed ID: 12595890
[TBL] [Abstract][Full Text] [Related]
16. Cytoplasm-to-nucleus translocation of a herpesvirus tegument protein during cell division.
Elliott G; O'Hare P
J Virol; 2000 Mar; 74(5):2131-41. PubMed ID: 10666242
[TBL] [Abstract][Full Text] [Related]
17. Herpes simplex virus VP22 enhances adenovirus-mediated microdystrophin gene transfer to skeletal muscles in dystrophin-deficient (mdx) mice.
Xiong F; Xiao S; Peng F; Zheng H; Yu M; Ruan Y; Li W; Shang Y; Zhao C; Zhou W; Chen H; Chamberlain JS; Fang L; Zhang C
Hum Gene Ther; 2007 Jun; 18(6):490-501. PubMed ID: 17550336
[TBL] [Abstract][Full Text] [Related]
18. Microtubule reorganization during herpes simplex virus type 1 infection facilitates the nuclear localization of VP22, a major virion tegument protein.
Kotsakis A; Pomeranz LE; Blouin A; Blaho JA
J Virol; 2001 Sep; 75(18):8697-711. PubMed ID: 11507215
[TBL] [Abstract][Full Text] [Related]
19. Distinctions between bovine herpesvirus 1 and herpes simplex virus type 1 VP22 tegument protein subcellular associations.
Harms JS; Ren X; Oliveira SC; Splitter GA
J Virol; 2000 Apr; 74(7):3301-12. PubMed ID: 10708447
[TBL] [Abstract][Full Text] [Related]
20. The study of the intercellular trafficking of the fusion proteins of herpes simplex virus protein VP22.
Xue X; Huang J; Wang H
PLoS One; 2014; 9(6):e100840. PubMed ID: 24955582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
